Search Login Register

Erythromycin Ethylsuccinate (E-Mycin E) Summary

Description: A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.

Also Known As: E-Mycin E; EryPed; Erythroped; Eyrthromycin Ethyl Succinate; Pediamycin Show All >>

Networked: 123 relevant articles (12 outcomes, 22 trials/studies) for this Drug

Key Diseases for which Erythromycin Ethylsuccinate is Relevant

  1. Impetigo : 3 outcomes 3 studies in 4 results
  2. Respiratory Tract Infections (Respiratory Tract Infection) : 2 outcomes 4 studies in 7 results
  3. Otitis Media : 2 outcomes in 8 results
  4. Pharyngitis (Sore Throat) : 1 outcome 2 studies in 5 results
  5. Dysentery : 1 outcome 1 study in 8 results
Show All >>

Drugs Related to Erythromycin Ethylsuccinate

  1. Mupirocin (Bactroban)
  2. Anti-Bacterial Agents (Antibiotics)
  3. Amoxicillin (Wymox)
  4. Ciprofloxacin (Cipro)
  5. Ampicillin (Omnipen)
  6. Roxithromycin
  7. Sulfisoxazole (Sulfafurazole)
  8. Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
  9. Clavulanic Acid (Potassium Clavulanate)
  10. ekmolin
Show All >>

Therapies Related to Erythromycin Ethylsuccinate

  1. Tonsillectomy
  2. Sutures (Suture)
  3. Middle Ear Ventilation (Tympanostomy)
  4. Aftercare (After-Treatment)
  5. Adenoidectomy

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.